Literature DB >> 21945941

The suitability of concentration addition for predicting the effects of multi-component mixtures of up to 17 anti-androgens with varied structural features in an in vitro AR antagonist assay.

Sibylle Ermler1, Martin Scholze, Andreas Kortenkamp.   

Abstract

The risks associated with human exposures to chemicals capable of antagonising the effects of endogenous androgens have attracted considerable recent interest. Exposure is typically to large numbers of chemicals with androgen receptor (AR) antagonist activity, yet there is limited evidence of the combined effects of multi-component mixtures of these chemicals. A few in vitro studies with mixtures of up to six AR antagonists suggest that the concept of concentration addition (CA) provides good approximations of experimentally observed mixture effects, but studies with larger numbers of anti-androgens, and with more varied structural features, are missing. Here we show that the mixture effects of up to 17 AR antagonists, comprising compounds as diverse as UV-filter substances, parabens, perfluorinated compounds, bisphenol-A, benzo(α)pyrene, synthetic musks, antioxidants and polybrominated biphenyls, can be predicted well on the basis of the anti-androgenicity of the single components using the concept of CA. We tested these mixtures in an in vitro AR-dependent luciferase reporter gene assay, based on MDA-kb2 cells. The effects of further mixtures, composed of four and six anti-androgens, could be predicted accurately by CA. However, there was a shortfall from expected additivity with a ten-component mixture at two different mixture ratios, but attempts to attribute these deviations to differential expression of hormone-metabolising CYP isoforms did not produce conclusive results. CA provides good approximations of in vitro mixture effects of anti-androgens with varying structural features.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945941     DOI: 10.1016/j.taap.2011.09.005

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

1.  Predicting the Activation of the Androgen Receptor by Mixtures of Ligands Using Generalized Concentration Addition.

Authors:  Jennifer J Schlezinger; Wendy Heiger-Bernays; Thomas F Webster
Journal:  Toxicol Sci       Date:  2020-10-01       Impact factor: 4.849

2.  Reconnaissance of Mixed Organic and Inorganic Chemicals in Private and Public Supply Tapwaters at Selected Residential and Workplace Sites in the United States.

Authors:  Paul M Bradley; Dana W Kolpin; Kristin M Romanok; Kelly L Smalling; Michael J Focazio; Juliane B Brown; Mary C Cardon; Kurt D Carpenter; Steven R Corsi; Laura A DeCicco; Julie E Dietze; Nicola Evans; Edward T Furlong; Carrie E Givens; James L Gray; Dale W Griffin; Christopher P Higgins; Michelle L Hladik; Luke R Iwanowicz; Celeste A Journey; Kathryn M Kuivila; Jason R Masoner; Carrie A McDonough; Michael T Meyer; James L Orlando; Mark J Strynar; Christopher P Weis; Vickie S Wilson
Journal:  Environ Sci Technol       Date:  2018-11-21       Impact factor: 9.028

3.  Seven benzimidazole pesticides combined at sub-threshold levels induce micronuclei in vitro.

Authors:  Sibylle Ermler; Martin Scholze; Andreas Kortenkamp
Journal:  Mutagenesis       Date:  2013-04-01       Impact factor: 3.000

4.  Mixed organic and inorganic tapwater exposures and potential effects in greater Chicago area, USA.

Authors:  Paul M Bradley; Maria Argos; Dana W Kolpin; Shannon M Meppelink; Kristin M Romanok; Kelly L Smalling; Michael J Focazio; Joshua M Allen; Julie E Dietze; Michael J Devito; Ariel R Donovan; Nicola Evans; Carrie E Givens; James L Gray; Christopher P Higgins; Michelle L Hladik; Luke R Iwanowicz; Celeste A Journey; Rachael F Lane; Zachary R Laughrey; Keith A Loftin; R Blaine McCleskey; Carrie A McDonough; Elizabeth Medlock-Kakaley; Michael T Meyer; Andrea R Putz; Susan D Richardson; Alan E Stark; Christopher P Weis; Vickie S Wilson; Abderrahman Zehraoui
Journal:  Sci Total Environ       Date:  2020-02-11       Impact factor: 10.753

5.  Effects of Common Pesticides on Prostaglandin D2 (PGD2) Inhibition in SC5 Mouse Sertoli Cells, Evidence of Binding at the COX-2 Active Site, and Implications for Endocrine Disruption.

Authors:  Subramaniam Kugathas; Karine Audouze; Sibylle Ermler; Frances Orton; Erika Rosivatz; Martin Scholze; Andreas Kortenkamp
Journal:  Environ Health Perspect       Date:  2015-09-11       Impact factor: 9.031

6.  Endocrine Disruption in Human Fetal Testis Explants by Individual and Combined Exposures to Selected Pharmaceuticals, Pesticides, and Environmental Pollutants.

Authors:  Pierre Gaudriault; Séverine Mazaud-Guittot; Vincent Lavoué; Isabelle Coiffec; Laurianne Lesné; Nathalie Dejucq-Rainsford; Martin Scholze; Andreas Kortenkamp; Bernard Jégou
Journal:  Environ Health Perspect       Date:  2017-08-04       Impact factor: 9.031

7.  Additive mixture effects of estrogenic chemicals in human cell-based assays can be influenced by inclusion of chemicals with differing effect profiles.

Authors:  Richard Mark Evans; Martin Scholze; Andreas Kortenkamp
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

8.  Competitive androgen receptor antagonism as a factor determining the predictability of cumulative antiandrogenic effects of widely used pesticides.

Authors:  Frances Orton; Erika Rosivatz; Martin Scholze; Andreas Kortenkamp
Journal:  Environ Health Perspect       Date:  2012-09-10       Impact factor: 9.031

9.  Mind the gap: can we explain declining male reproductive health with known antiandrogens?

Authors:  Andreas Kortenkamp; Martin Scholze; Sibylle Ermler
Journal:  Reproduction       Date:  2014-03-02       Impact factor: 3.906

10.  In vitro impact of five pesticides alone or in combination on human intestinal cell line Caco-2.

Authors:  Sylvain Ilboudo; Edwin Fouche; Virginie Rizzati; Adama M Toé; Laurence Gamet-Payrastre; Pierre I Guissou
Journal:  Toxicol Rep       Date:  2014-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.